BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Duijneveldt G, Griffin MDW, Putoczki TL. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clin Sci (Lond) 2020;134:2091-115. [PMID: 32808663 DOI: 10.1042/CS20191211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Meessen S, Currey N, Jahan Z, Parker HW, Jenkins MA, Buchanan DD, Hopper JL, Segelov E, Dahlstrom JE, Kohonen-Corish MRJ. Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer. Cancers (Basel) 2021;13:3529. [PMID: 34298744 DOI: 10.3390/cancers13143529] [Reference Citation Analysis]
2 Li Y, Al Hallak MN, Philip PA, Azmi AS, Mohammad RM. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs. Cancers (Basel) 2021;13:4161. [PMID: 34439315 DOI: 10.3390/cancers13164161] [Reference Citation Analysis]
3 Bhatia R, Bhyravbhatla N, Kisling A, Li X, Batra SK, Kumar S. Cytokines Chattering in Pancreatic Ductal Adenocarcinoma Tumor Microenvironment. Semin Cancer Biol 2022:S1044-579X(22)00077-3. [PMID: 35346801 DOI: 10.1016/j.semcancer.2022.03.021] [Reference Citation Analysis]
4 Vaish U, Jain T, Are AC, Dudeja V. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. Int J Mol Sci 2021;22:13408. [PMID: 34948209 DOI: 10.3390/ijms222413408] [Reference Citation Analysis]
5 Candido S, Tomasello BMR, Lavoro A, Falzone L, Gattuso G, Libra M. Novel Insights into Epigenetic Regulation of IL6 Pathway: In Silico Perspective on Inflammation and Cancer Relationship. Int J Mol Sci 2021;22:10172. [PMID: 34576335 DOI: 10.3390/ijms221810172] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang Z, Zhang H, Liu T, Chen T, Wang D, Tang D. Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. Front Cell Dev Biol 2021;9:783617. [PMID: 34988078 DOI: 10.3389/fcell.2021.783617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pednekar KP, Heinrich MA, van Baarlen J, Prakash J. Novel 3D µtissues Mimicking the Fibrotic Stroma in Pancreatic Cancer to Study Cellular Interactions and Stroma-Modulating Therapeutics. Cancers (Basel) 2021;13:5006. [PMID: 34638490 DOI: 10.3390/cancers13195006] [Reference Citation Analysis]
8 Orlacchio A, Mazzone P. The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology. Int J Mol Sci 2021;22:12743. [PMID: 34884547 DOI: 10.3390/ijms222312743] [Reference Citation Analysis]
9 Dufrusine B, Damiani V, Capone E, Pieragostino D, Dainese E, De Marco M, Reppucci F, Turco MC, Rosati A, Marzullo L, Sala G, Sallese M, De Laurenzi V. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration. J Cell Biochem 2021. [PMID: 34741485 DOI: 10.1002/jcb.30172] [Reference Citation Analysis]
10 Tsai WC, Wang WH, Huang BC, Huang CY, Sheu JH. 5-epi-Sinuleptolide from Soft Corals of the Genus Sinularia Exerts Cytotoxic Effects on Pancreatic Cancer Cell Lines via the Inhibition of JAK2/STAT3, AKT, and ERK Activity. Molecules 2021;26:6932. [PMID: 34834023 DOI: 10.3390/molecules26226932] [Reference Citation Analysis]
11 Li Y, Wang J, Wang H, Zhang S, Wei Y, Liu S. The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer. Front Immunol 2022;13:850093. [DOI: 10.3389/fimmu.2022.850093] [Reference Citation Analysis]
12 Peisl S, Mellenthin C, Vignot L, Gonelle-Gispert C, Bühler L, Egger B. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. PLoS One 2021;16:e0252397. [PMID: 34138876 DOI: 10.1371/journal.pone.0252397] [Reference Citation Analysis]
13 Magni L, Bouazzi R, Heredero Olmedilla H, Petersen PSS, Tozzi M, Novak I. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells. Cells 2021;10:1928. [PMID: 34440697 DOI: 10.3390/cells10081928] [Reference Citation Analysis]